# Editorial: Understanding how myeloid cell development and function meet tissue distinct metabolic requirements

**Authors:** Erika M. Palmieri, Robert J. Salmond, Alessio Menga

PMC · DOI: 10.3389/fimmu.2024.1373468 · Frontiers in Immunology · 2024-02-07

## Full-text entities

- **Genes:** Lgals3 (lectin, galactose binding, soluble 3) [NCBI Gene 16854] {aka GBP, L-34, Mac-2, gal3}, PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta) [NCBI Gene 5293] {aka APDS, IMD14, IMD14A, IMD14B, P110DELTA, PI3K}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Esam (endothelial cell-specific adhesion molecule) [NCBI Gene 69524] {aka 2310008D05Rik, Esam1, W117m}, Mir690 (microRNA 690) [NCBI Gene 751543] {aka Mirn690, mir-690, mmu-mir-690}, Ccr2 (C-C motif chemokine receptor 2) [NCBI Gene 12772] {aka Cc-ckr-2, Ccr2a, Ccr2b, Ckr2, Ckr2a, Ckr2b}, Acod1 (aconitate decarboxylase 1) [NCBI Gene 16365] {aka CAD, Irg1}, Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, Trem1 (triggering receptor expressed on myeloid cells 1) [NCBI Gene 58217], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, Ccr5 (C-C motif chemokine receptor 5) [NCBI Gene 12774] {aka AM4-7, CD195, Cmkbr5}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}
- **Diseases:** lung damage (MESH:D008171), leukemia (MESH:D007938), organ injury (MESH:D009102), lung injury (MESH:D055370), NAFLD (MESH:D065626), necrotic (MESH:D009336), AML (MESH:D015470), infections (MESH:D007239), MPN (MESH:D009369), immune dysfunction (MESH:D007154), inflammation (MESH:D007249), fibrosis (MESH:D005355), ARDS (MESH:D012128), insulin resistance (MESH:D007333), radiation injury (MESH:D011832), MF (MESH:D055728), NASH (MESH:D005235), COPD (MESH:D029424), hypercytokinemia (MESH:D000080424), oncogenesis (MESH:D063646), Liver macrophages (MESH:D017093), blood cancer (MESH:D019337), cytogenetic abnormalities (MESH:D002869), hepatic (MESH:D056486)
- **Chemicals:** NO (MESH:D009569), glucose (MESH:D005947), itaconic acid (MESH:C005229), ROS (MESH:D017382), carotenoids (MESH:D002338), lipid (MESH:D008055), oxidized (-), methicillin (MESH:D008712), Carbohydrate (MESH:D002241), fatty acids (MESH:D005227), oxygen (MESH:D010100)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Influenza A virus (no rank) [taxon 11320], Staphylococcus aureus (species) [taxon 1280]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10879609/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC10879609/full.md

---
Source: https://tomesphere.com/paper/PMC10879609